Nanjing RegeneCore Biotech Co.,Ltd is established in the Biomedical Valley of National Nanjing Jiangbei New Area, with a research and office base of nearly 4000 square meters. It is one of the first research and development institutions in the field of nanobodies in China. 

The company's international scientific consulting expert team has rich experience in the research and development of cell therapy products and clinical applications, providing strong guarantees for the precise positioning and success rate of research and development products. The company has mature and leading nanobody screening technology, and conducts in-depth development in multiple application fields based on this technology.

At present, RegeneCore's research and development direction covers the fields of neurobiology research, biopharmaceuticals based on nanobody technology, and cell therapy using nanobody technology. The company has established a mature and complete nanobody humanization technology platform, antibody immunogenicity testing technology platform, and high-throughput nanobody screening technology platform.

Regenecore has established institutes with high-level integration of industry and education and innovative mechanisms - Thoth Institutes for Health Research. The institutes are committed to high-level application-oriented research and rapid transformation of achievements, catering to the life and health of the people and the forefront of world technology.

RegeneCore is a dynamic, proactive, pragmatic, and enterprising platform.We welcome ambitious individuals to join us.

YOUNGY INVESTMENT HOLDING GROUP CO.,LTD

YOUNGY INVESTMENT HOLDING GROUP CO.,LTD has invested in exceeds 900 billion RMB at present, the asset scale and annual operating income both exceed 300 billion RMB,and the employees exceed 350,000. The industry involve more than 10 industries,such as new energy, flexible display, intelligent education, health intelligence, lifetechnology, finance and insurance, capital operation, etc. Industrial bases and branches are distributed in many countries and regions around the world.

For a long time, YOUNGY has been adhering to the corporate philosophy of "excellence, progress, equality, integrity and win-win" and adhering to the principle of "value discovery, accurate investment, and leverage of value increment". Resource integration, excellent operation, do resource allocation platform "business strategy, is committed to" build a world-class investment holding platform ". So far, Youngy has successfully built two platforms of "industrial investment" and "capital operation", and has shaped the high-end brand image of the industry. BYD, a strategic investment company of YOUNGY, has become a landmark company in the global new energy industry.Today, BYD's production and sales of electric vehicles rank first in the world; YOUNGY took the lead in seizing the commanding height of lithium resources in the global new energy industry chain with its investment in the solid Spodumene mine in Ganzi Prefecture, Sichuan Province in 2005; YOUNGY has developed a color electrophoretic display technology product, the e-book pack, which integrates health, intelligence, low-carbon, and environmental protection. It can completely replace paper textbooks in teaching and is playing an active leading role in the global modernization of education.

"To create value for the society, to accumulate wealth for the enterprise, to create a career platform for aspiring talents, to win a better life for like-minded people" is our purpose and mission.YOUNGY is willing to work hand in hand with all people of insight to achieve "our YOUNGY, the world's YOUNGY" and strive hard!